PCV49 COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PORTUGUESE PATIENTS
Abstract
Authors
F. de Andrés-Nogales P.R. Gay-Pobes M. Inês C. Polanco Sánchez D. Alves I. Oyagüez